Clincosm LogoSign in Get a demo

pci

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coronary Artery Disease, Aortic Valve Stenosis, TAVI Trial in Worldwide (PCI)

Active, not recruiting
  • Coronary Artery Disease
  • +3 more
  • PCI
  • Aalborg, Denmark
  • +11 more
Nov 8, 2022

Aortic Stenosis, Coronary Artery Disease, TAVI Trial in Zürich (PCI before TAVI, PCI after TAVI)

Recruiting
  • Aortic Stenosis
  • +3 more
  • PCI before TAVI
  • PCI after TAVI
  • Zürich, Switzerland
    University Hospital Zürich, Cardiology Department
Oct 5, 2021

Cardiac Disease, PCI, High Bleeding Risk Trial in Netherlands (Supraflex Cruz 60 Micron, Ultimaster Tansei 80 Micron)

Recruiting
  • Cardiac Disease
  • +2 more
  • Supraflex Cruz 60 Micron
  • Ultimaster Tansei 80 Micron
  • 's-Hertogenbosch, Netherlands
  • +10 more
Sep 13, 2021

High Bleeding Risk, Coronary Artery Disease, PCI Trial in Worldwide (Aspirin, P2Y12 inhibitor)

Completed
  • High Bleeding Risk
  • +2 more
  • Buenos Aires, Argentina
  • +137 more
Aug 19, 2021

Age-Dependent Impact of the SYNTAX-score on Mortality

Completed
  • Coronary Artery Disease
  • PCI
  • PCI
  • Munich, Germany
    Ludwig-Maximilians University
Aug 7, 2018

Plasma Dipeptidyl-peptidase-4 Activities With No-reflow and

Completed
  • Dipeptidyl-peptidase-4
  • +4 more
    • (no location specified)
    Jul 26, 2016

    Coagulation and Thrombocyte Function After Termination of

    Completed
    • PCI
    • Coronary Stents
      • Örebro, Sweden
        University Hospital
      Sep 26, 2015